Table: begin end state 1 6 cytoplasmic 7 25 transmembrane 26 27 cytoplasmic 28 29 non-cytoplasmic 30 53 transmembrane 54 62 cytoplasmic 63 64 non-cytoplasmic 65 80 transmembrane 81 104 non-cytoplasmic 105 131 transmembrane 132 142 cytoplasmic 143 161 transmembrane 162 180 non-cytoplasmic 181 204 transmembrane 205 246 cytoplasmic 247 267 transmembrane 268 288 non-cytoplasmic 289 308 transmembrane 309 319 cytoplasmic 320 338 transmembrane 339 351 non-cytoplasmic 352 372 transmembrane 373 378 cytoplasmic 379 399 transmembrane 400 404 non-cytoplasmic 405 428 transmembrane 429 439 cytoplasmic 440 464 transmembrane 465 465 non-cytoplasmic
Input: >BPHYT_RS16725 MEAVHGSTLLVFAVIAIALLILLITRYKVYPFLVLIIVSLLLGLASGMPMATIVKSFETG NGNTLGHIAIVVGLGTMLGKMMAESGGAERIATTLIDFFGEKNIHWAMMIVAIIVGLPVF FEVGFVLLIPIAFNVAKRTNKSLLLVGLPMVAGLSVVHGLLPPHPAAMLAVQAYHADIGR TIAYGLIVGVPTAIVAGPLFALMISRYIKLPKENALAAQFLGHGDETKNGAQTAAQNVAP KRELPSFGITLLTILLPVILMLVGSWADLFTTPKTLPNDLLHFAGNSDVALLIAVLVSFW TFGASRGFTREQIQKFCGDCLAPIAGITLIVGAGGGFGRVLMDSGISKEIVNVATAMHLS PLLFGWLVAALIRLATGSATVAMTTACGIVAPIASASGVHVEPELLVLATGSGSLIFSHV NDGGFWLIKEYFGMTVGQTFKTWSLLETIISLMGLGLTFALAAVV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server